230 related articles for article (PubMed ID: 24748570)
1. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
2. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
[TBL] [Abstract][Full Text] [Related]
3. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
Li CI; Weiss NS; Stanford JL; Daling JR
Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
[TBL] [Abstract][Full Text] [Related]
5. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
[TBL] [Abstract][Full Text] [Related]
6. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
Fournier A; Fabre A; Mesrine S; Boutron-Ruault MC; Berrino F; Clavel-Chapelon F
J Clin Oncol; 2008 Mar; 26(8):1260-8. PubMed ID: 18323549
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
[TBL] [Abstract][Full Text] [Related]
8. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
[TBL] [Abstract][Full Text] [Related]
11. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
13. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
[TBL] [Abstract][Full Text] [Related]
14. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
Reeves GK; Beral V; Green J; Gathani T; Bull D;
Lancet Oncol; 2006 Nov; 7(11):910-8. PubMed ID: 17081916
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.
Kjartansdottir OJ; Sigurdardottir LG; Olafsdottir EJ; Jonasson JG; Ursin G; Tryggvadottir L
Breast Cancer Res Treat; 2017 Jun; 163(2):363-373. PubMed ID: 28281022
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.
Hein R; Flesch-Janys D; Dahmen N; Beckmann L; Lindström S; Schoof N; Czene K; Mittelstraß K; Illig T; Seibold P; Behrens S; Humphreys K; Li J; Liu J; Olson JE; Wang X; Hankinson SE; Truong T; Menegaux F; Dos Santos Silva I; Johnson N; ; Chen ST; Yu JC; Ziogas A; Kataja V; Kosma VM; Mannermaa A; Anton-Culver H; Shen CY; Brauch H; Peto J; Guénel P; Kraft P; Couch FJ; Easton DF; Hall P; Chang-Claude J
Breast Cancer Res Treat; 2013 Apr; 138(2):529-542. PubMed ID: 23423446
[TBL] [Abstract][Full Text] [Related]
18. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study.
Lew JQ; Freedman ND; Leitzmann MF; Brinton LA; Hoover RN; Hollenbeck AR; Schatzkin A; Park Y
Am J Epidemiol; 2009 Aug; 170(3):308-17. PubMed ID: 19541857
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
